Heartland Health Care Center-hampton | |
800 Mulholland Rd, Bay City, Michigan 48708 | |
(989) 895-8539 | |
Name | Heartland Health Care Center-hampton |
---|---|
Location | 800 Mulholland Rd, Bay City, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 51 |
Occupancy Rate | 45.69% |
Medicare ID (CCN) | 235411 |
Legal Business Name | Heartland-hampton Of Bay City Mi Llc |
Ownership Type | Non Profit - Corporation |
NPI Number | 1902847775 |
Organization Name | HEARTLAND-HAMPTON OF BAY CITY MI, LLC |
Doing Business As | PROMEDICA SKILLED NURSING AND REHABILITATION (BAY CITY) |
Address | 800 Mulholland St, Bay City, MI 48708 |
Phone Number | 989-895-8539 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
It has been identified by the World Health Organization as the most dangerous infectious disease, causing more deaths - more than 2 million a year - than any other single infection. Approximately one-third of the world's population is already infected.
Scientists at Queen's University Belfast are hoping to develop a novel approach that could save the sight of millions of diabetes sufferers using adult stem cells.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
It has been identified by the World Health Organization as the most dangerous infectious disease, causing more deaths - more than 2 million a year - than any other single infection. Approximately one-third of the world's population is already infected.
Scientists at Queen's University Belfast are hoping to develop a novel approach that could save the sight of millions of diabetes sufferers using adult stem cells.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.5 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.45 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 32.14 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.47 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 7.06 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.06 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 7.59 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.8 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.78 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 37.52 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 48.75 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 9.72 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 80.61 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.11 | 82.93 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.
Scripps Research Institute scientists have discovered a basic mechanism that can enable developing cancer cells to sustain abnormal growth. The finding is expected to lead to the targeting of this mechanism with drugs and diagnostic techniques.
It has been identified by the World Health Organization as the most dangerous infectious disease, causing more deaths - more than 2 million a year - than any other single infection. Approximately one-third of the world's population is already infected.
Scientists at Queen's University Belfast are hoping to develop a novel approach that could save the sight of millions of diabetes sufferers using adult stem cells.
› Verified 3 days ago
Bay Shores Senior Care And Rehab Center Location: 3254 E Midland Rd, Bay City, Michigan 48706 Phone: (989) 686-3770 | |
Heartland Health Care Center-hampton Location: 800 Mulholland Rd, Bay City, Michigan 48708 Phone: (989) 895-8539 | |
Carriage House Nursing And Rehab Location: 2394 Midland Rd, Bay City, Michigan 48706 Phone: (989) 684-2303 | |
Caretel Inns Of Tri-cities Location: 6700 Westside Saginaw Road, Bay City, Michigan 48706 Phone: (989) 667-9800 |